CDT1 was found to be highly elevated in a variety of malignancies when compared to normal tissues, according to a pan-cancer analysis utilizing Wilcoxon rank-sum and Wilcoxon signed-rank tests (Fig. 1A, P < 0.001). Here, CDT1 is linked to cancer.